Back to School: How biopharma can reboot drug development. Access exclusive analysis here

What drives biopesticide merger

What drives biopesticide merger

Biopesticide developers Biosys Inc. and Crop Genetics International have signed a merger agreement that will give BIOS access to CROP's in vivo baculovirus production process and its cash.

In the proposed merger, which will be treated as a pooling of interests, BIOS will issue 2.1 million new shares to acquire CROP's 10.8 million common shares, and will issue 1.4 million new shares

Read the full 655 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE